Over 400,000 U.S. service members have been diagnosed with TBI since 2000, and that figure undercounts blast exposure that never reached formal diagnosis. The measurement gap is not theoretical — it has shaped careers, benefits decisions, and long-term health.
Blood-based biomarkers offer a path to standardized, mission-compatible screening that closes that gap.